)
Visual
earnings real time
IDEXX Laboratories
IDEXX Laboratories (IDXX) investor relations material
IDEXX Laboratories Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary2 Feb, 2026
Executive summary
Q4 2025 revenue grew 14% as reported and 12% organically, driven by strong CAG Diagnostics recurring revenue and record premium instrument placements.
Full-year 2025 revenue reached $4,304 million, up 10% year-over-year, with EPS of $13.08, a 23% increase as reported.
Expanded global commercial presence and launched key innovations, including inVue Dx and Cancer Dx, supporting recurring revenue and high customer retention.
Financial highlights
Q4 revenue: $1,091 million, up 14% reported and 12% organic; CAG revenue up 15% reported and 13% organic.
Q4 EPS: $3.08, up 18% year-over-year; full-year EPS: $13.08, up 23%.
Q4 operating profit was $316 million (29% of revenue); full-year operating margin: 31.6%.
Free cash flow for 2025 was $1.1 billion, 100% of net income; $1.2 billion allocated to share repurchases.
Gross margin for 2025 was 61.8%, up 80 basis points year-over-year.
Outlook and guidance
2026 revenue guidance: $4,632–$4,720 million, up 7.6%–9.6% reported, 7%–9% organic.
2026 EPS outlook: $14.29–$14.80, up 9%–13% reported and 10%–14% comparable.
Operating margin guidance for 2026: 32.0%–32.5%, with 30–90 basis points improvement.
CAG Diagnostics recurring revenue expected to grow 8%–10% organically in 2026.
Free cash flow conversion expected at 85%–95% of net income; $180 million in capital spending planned.
How does innovation drive broader portfolio growth
Impact of aging pets on 2026 visit trends
How to offset 2026 CAG instrument revenue decline
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 323410
Strong growth in customers, profits, and deposits, with stable asset quality and global milestones. - 3407
Net income rose 22.7% year-over-year, with improved financials and a revised upward forecast. - RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m cash release, and resumed dividends by FY 2028. - 9101
Profits fell across most segments, but energy shipping and a major acquisition stood out. - 4626
Double-digit profit and sales growth, with strong segment results and a stock split impact. - 2371
Revenue up 21.5% YoY, but profit down on higher investments; LiPLUS Holdings acquired. - 3401
Major impairments and divestitures led to a net loss and lower revenue across all segments. - 8002
Profit forecast raised to ¥540.0B and annual dividend to ¥107.50 per share after strong results. - COF
Profit rebounded, NTA and occupancy rose, with strong leasing and premium divestment. - NUF
Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed.
Next IDEXX Laboratories earnings date
Q1 202630 Apr, 2026
IDEXX Laboratories
Next IDEXX Laboratories earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
IDEXX Laboratories, Inc. operates in four segments: Companion Animal Group, Water Quality Products, Livestock, Poultry and Dairy and Other. The CAG segment offers products and services primarily to veterinarians for the detection, diagnosis, treatment, monitoring and prevention of diseases and other conditions in dogs, cats, horses and other companion animals. The WQP segment offers on-site instruments, consumables, disinfectants, water quality testing services and related plate count products for the detection of total coliforms and Escherichia coli in drinking water.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage